The most reported GLP-1 side effects are gastrointestinal: nausea, diarrhea, constipation, and abdominal pain, and they tend to be worst early and when a dose increases. Less visible, but just as important, is what a monitored program tracks over time, which is where labs and scheduled follow-up come in. This is the difference a physician-led plan is meant to make, especially with compounded medications, which are not FDA-approved.
The common side effects, and why they happen
GLP-1 medications slow how fast the stomach empties and change appetite signaling, so most side effects are digestive: nausea, reduced appetite, diarrhea, constipation, and abdominal pain. They are usually most noticeable in the first weeks and after each dose step-up, and they often settle as the body adjusts. That pattern is one reason a prescriber raises a dose gradually rather than quickly.
What a monitored program actually watches
How you feel is only part of the picture. A physician-led program documents side effects, dose changes, and labs at intervals over the year, with follow-up often set around 1, 3, 6, and 12 months. Metabolic markers such as HbA1c and fasting glucose, plus other labs the physician selects, give an objective read on how the body is responding rather than relying on symptoms alone. (See the GLP-1 metabolic panel and HbA1c and fasting insulin.)
you are
Add what fits. Consent happens at checkout, prescriptions come from independent licensed providers, and weight and hormone paths include a consult. Browse the shop →
Muscle is a marker too
Rapid changes in body composition can affect lean muscle, not just fat, which is why a thoughtful program pays attention to protein intake, resistance training, and markers that track muscle rather than watching a single figure on the scale. The goal a physician works toward is fat loss with muscle preserved, not loss at any cost. (See GLP-1 and muscle: the markers.)
The safety difference with compounded GLP-1
Compounded tirzepatide and semaglutide are not FDA-approved, and regulators have noted that many reported problems with compounded products trace back to dosing errors from self-administration rather than the molecule itself. That is the core case for a licensed prescriber: correct dosing, a real titration schedule, and someone reading your labs. Compounded medicine is legitimate when a physician prescribes and monitors it; it is riskiest when people self-source and self-dose. (See what compounded GLP-1 means and tirzepatide vs semaglutide.)
What your physician does (labs before molecules)
At Telos, the information you provide and the panel you complete are reviewed by a licensed physician through the affiliated medical group. They decide whether a GLP-1 program is appropriate, at what dose, and what to monitor and how often. The core hormone and health panel gives a baseline first, so side effects and progress are read against real numbers rather than guesswork. Measure first, then decide: labs before molecules. Nothing here is medical advice.
